TUCSON, AZ -- (MARKET WIRE) -- May 16, 2007 -- CDEX's (OTCBB: CEXI) founding CEO and Chairman, Malcolm Philips, will be interviewed by MN1 on May 17, 2007, at 12:30 PM EDT to discuss the general structure of CDEX and it's technology, the Beta Cycle trials of CDEX's Methamphetamine Detection Unit, the Company's Medical product line -- ValiMed™ and CDEX's ongoing research programs. "We believe that our company is poised for growth in the marketplace and we are starting the process of introducing potential investors to this opportunity," said Mr. Philips.
